-
Bogers W M, Cheng-Mayer C, Montelaro R C. Developments in preclinical aids vaccine efficacy models[J]. AIDS, 2000, 14(Suppl 3): S141-S151.
-
Burton D R, Desrosiers R C, Doms R W. Hiv vaccine design and the neutralizing antibody problem[J]. Nat Immunol, , 5(3): 233-236. doi: 10.1038/ni0304-233
-
Cavarelli M, Karlsson I, Zanchetta M. Hiv-1 with multiple ccr5/cxcr4 chimeric receptor use is predictive of immunological failure in infected children[J]. PLoS One, 2008, 3(9): e3292-. doi: 10.1371/journal.pone.0003292
-
Clements J E, Zink M C. Molecular biology and pathogenesis of animal lentivirus infections[J]. Clin Microbiol Rev, 1996, 9(1): 100-117.
-
Craigo J K, Zhang B, Barnes S. Envelope variation as a primary determinant of lentiviral vaccine efficac[J]. Proc Natl Acad Sci U S A, 2007, 104(38): 15105-15110. doi: 10.1073/pnas.0706449104
-
Desrosiers R C. Prospects for an aids vaccine[J]. Nat Med, 2004, 10(3): 221-223. doi: 10.1038/nm0304-221
-
Felsenstein J. Inferring phylogenies from protein sequences by parsimony, distance, and likelihood methods[J]. Methods Enzymol, 1996, 266(): 418-427. doi: 10.1016/S0076-6879(96)66026-1
-
Johnson W E, Sanford H, Schwall L. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities[J]. J Virol, 2003, 77(18): 9993-10003. doi: 10.1128/JVI.77.18.9993-10003.2003
-
Kuiken C, Korber B, Shafer R W. Hiv sequence databases[J]. AIDS Rev, 2003, 5(1): 52-61.
-
Leroux C, Cadore J L, Montelaro R C. Equine infectious anemia virus (eiav): What has hiv's country cousin got to tell us?[J]. Vet Res, 2004, 35(4): 485-512. doi: 10.1051/vetres:2004020
-
Liang H, He X, Shen R X. Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of eiav[J]. Arch Virol, 2006, 151(7): 1387-1403. doi: 10.1007/s00705-005-0718-3
-
Losman B, Bolmstedt A, Schonning K. Protection of neutralization epitopes in the v3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by n-linked oligosaccharides in the v1 region[J]. AIDS Res Hum Retroviruses, 2001, 17(11): 1067-1076. doi: 10.1089/088922201300343753
-
Losman B, Biller M, Olofsson S. The n-linked glycan of the v3 region of hiv-1 gp120 and cxcr4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant[J]. FEBS Lett, 1999, 454(1-2): 47-52. doi: 10.1016/S0014-5793(99)00740-1
-
Means R E, Greenough T, Desrosiers R C. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus[J]. J Virol, 1997, 71(10): 7895-7902.
-
Mellquist J L, Bowman B, Kasturi L. Characterization of hiv type 1 gp120 v3 region sequences from ugandan infants[J]. AIDS Res Hum Retroviruses, 1998, 14(15): 1391-1395. doi: 10.1089/aid.1998.14.1391
-
Miyauchi K, Curran A R, Long Y. The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the hiv envelope protein[J]. Retrovirology, , 7(): 95-. doi: 10.1186/1742-4690-7-95
-
Mori K, Yasutomi Y, Ohgimoto S. Quintuple deglycosylation mutant of simian immunodeficiency virus sivmac239 in rhesus macaques: Robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain[J]. J Virol, 2001, 75(9): 4023-4028. doi: 10.1128/JVI.75.9.4023-4028.2001
-
Mori K, Sugimoto C, Ohgimoto S. Influence of glycosylation on the efficacy of an env-based vaccine against simian immunodeficiency virus sivmac239 in a macaque aids model[J]. J Virol, 2005, 79(16): 10386-10396. doi: 10.1128/JVI.79.16.10386-10396.2005
-
Ohgimoto S, Shioda T, Mori K. Location-specific, unequal contribution of the n glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity[J]. J Virol, 1998, 72(10): 8365-8370.
-
Payne S L, Pei X F, Jia B. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus[J]. J Virol, 2004, 78(5): 2478-2485. doi: 10.1128/JVI.78.5.2478-2485.2004
-
Reitter J N, Means R E, Desrosiers R C. A role for carbohydrates in immune evasion in aids[J]. Nat Med, 1998, 4(6): 679-684. doi: 10.1038/nm0698-679
-
Rice N R, Henderson L E, Sowder R C. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus[J]. J Virol, 1990, 64(8): 3770-3778.
-
Schonning K, Jansson B, Olofsson S. Rapid selection for an n-linked oligosaccharide by monoclonal antibodies directed against the v3 loop of human immunodeficiency virus type 1[J]. J Gen Virol, 1996, 77(Pt 4): 753-758.
-
Sellon D C, Fuller F J, McGuire T C. The immunopathogenesis of equine infectious anemia virus[J]. Virus Res, 1994, 32(2): 111-138. doi: 10.1016/0168-1702(94)90038-8
-
Shen R X, Xu Z D, HE Y S. Development of a eiav donkey leucocyte attenuated vaccine[J]. Sci Agr Sin, 1979, 4(): 1-15.
-
Shen T, Liang H, Tong X. Amino acid mutations of the infectious clone from chinese eiav attenuated vaccine resulted in reversion of virulence[J]. Vaccine, 2006, 24(6): 738-749. doi: 10.1016/j.vaccine.2005.08.084
-
Sjolander S, Bolmstedt A, Akerblom L. N-linked glycans in the cd4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of t cells recognizing an epitope located in their vicinit[J]. Virology, 1996, 215(2): 124-133. doi: 10.1006/viro.1996.0015
-
Sober E. The contest between parsimony and likelihood[J]. Syst Biol, 2004, 53(4): 644-653. doi: 10.1080/10635150490468657
-
Thompson J D, Gibson T J, Plewniak F. The clustal_x windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tool[J]. Nucleic Acids Res, 1997, 25(24): 4876-4882. doi: 10.1093/nar/25.24.4876
-
Tully D C, Wood C. Chronology and evolution of the hiv-1 subtype c epidemic in ethiopia[J]. AIDS, 2010, 24(10): 1577-1582. doi: 10.1097/QAD.0b013e32833999e1
-
Zhang H, Tully D C, Hoffmann F G. Restricted genetic diversity of hiv-1 subtype c envelope glycoprotein from perinatally infected zambian infants[J]. PLoS One, 2010, 5(2): e9294-. doi: 10.1371/journal.pone.0009294
-
Zhang M, Gaschen B, Blay W. Tracking global patterns of n-linked glycosylation site variation in highly variable viral glycoproteins: Hiv, siv, and hcv envelopes and influenza hemagglutinin[J]. Glycobiology, 2004, 14(12): 1229-1246. doi: 10.1093/glycob/cwh106